United States Pemetrexed Market Report 2018

January 2018 | 95 pages | ID: U05CB156441EN
QYResearch

Abstracts

In this report, the United States Pemetrexed market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pemetrexed in these regions, from 2012 to 2022 (forecast).

United States Pemetrexed market competition by top manufacturers/players, with Pemetrexed sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly
• Abbott Healthcare
• Cadila Healthcare

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 100mg
• 500mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Pleural Mesothelioma
• Non-small Cell Lung Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Pemetrexed Market Report 2017

1 PEMETREXED OVERVIEW

1.1 Product Overview and Scope of Pemetrexed
1.2 Classification of Pemetrexed by Product Category
  1.2.1 United States Pemetrexed Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Pemetrexed Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 100mg
  1.2.4 500mg
1.3 United States Pemetrexed Market by Application/End Users
  1.3.1 United States Pemetrexed Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Pleural Mesothelioma
  1.3.3 Non-small Cell Lung Cancer
1.4 United States Pemetrexed Market by Region
  1.4.1 United States Pemetrexed Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Pemetrexed Status and Prospect (2012-2022)
  1.4.3 Southwest Pemetrexed Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Pemetrexed Status and Prospect (2012-2022)
  1.4.5 New England Pemetrexed Status and Prospect (2012-2022)
  1.4.6 The South Pemetrexed Status and Prospect (2012-2022)
  1.4.7 The Midwest Pemetrexed Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pemetrexed (2012-2022)
  1.5.1 United States Pemetrexed Sales and Growth Rate (2012-2022)
  1.5.2 United States Pemetrexed Revenue and Growth Rate (2012-2022)

2 UNITED STATES PEMETREXED MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pemetrexed Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pemetrexed Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pemetrexed Average Price by Players/Suppliers (2012-2017)
2.4 United States Pemetrexed Market Competitive Situation and Trends
  2.4.1 United States Pemetrexed Market Concentration Rate
  2.4.2 United States Pemetrexed Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pemetrexed Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PEMETREXED SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Pemetrexed Sales and Market Share by Region (2012-2017)
3.2 United States Pemetrexed Revenue and Market Share by Region (2012-2017)
3.3 United States Pemetrexed Price by Region (2012-2017)

4 UNITED STATES PEMETREXED SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Pemetrexed Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pemetrexed Revenue and Market Share by Type (2012-2017)
4.3 United States Pemetrexed Price by Type (2012-2017)
4.4 United States Pemetrexed Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PEMETREXED SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Pemetrexed Sales and Market Share by Application (2012-2017)
5.2 United States Pemetrexed Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PEMETREXED PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Eli Lilly
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pemetrexed Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly Pemetrexed Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Healthcare
  6.2.2 Pemetrexed Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Healthcare Pemetrexed Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cadila Healthcare
  6.3.2 Pemetrexed Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cadila Healthcare Pemetrexed Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 PEMETREXED MANUFACTURING COST ANALYSIS

7.1 Pemetrexed Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pemetrexed

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pemetrexed Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pemetrexed Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PEMETREXED MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Pemetrexed Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pemetrexed Sales Volume Forecast by Type (2017-2022)
11.3 United States Pemetrexed Sales Volume Forecast by Application (2017-2022)
11.4 United States Pemetrexed Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pemetrexed
Figure United States Pemetrexed Market Size (Units) by Type (2012-2022)
Figure United States Pemetrexed Sales Volume Market Share by Type (Product Category) in 2016
Figure 100mg Product Picture
Figure 500mg Product Picture
Figure United States Pemetrexed Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Pemetrexed by Application in 2016
Figure Pleural Mesothelioma Examples
Table Key Downstream Customer in Pleural Mesothelioma
Figure Non-small Cell Lung Cancer Examples
Table Key Downstream Customer in Non-small Cell Lung Cancer
Figure United States Pemetrexed Market Size (Million USD) by Region (2012-2022)
Figure The West Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pemetrexed Sales (Units) and Growth Rate (2012-2022)
Figure United States Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pemetrexed Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Pemetrexed Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Pemetrexed Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pemetrexed Sales Share by Players/Suppliers
Figure 2017 United States Pemetrexed Sales Share by Players/Suppliers
Figure United States Pemetrexed Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pemetrexed Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pemetrexed Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pemetrexed Revenue Share by Players/Suppliers
Figure 2017 United States Pemetrexed Revenue Share by Players/Suppliers
Table United States Market Pemetrexed Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Pemetrexed Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Pemetrexed Market Share of Top 3 Players/Suppliers
Figure United States Pemetrexed Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pemetrexed Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pemetrexed Product Category
Table United States Pemetrexed Sales (Units) by Region (2012-2017)
Table United States Pemetrexed Sales Share by Region (2012-2017)
Figure United States Pemetrexed Sales Share by Region (2012-2017)
Figure United States Pemetrexed Sales Market Share by Region in 2016
Table United States Pemetrexed Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pemetrexed Revenue Share by Region (2012-2017)
Figure United States Pemetrexed Revenue Market Share by Region (2012-2017)
Figure United States Pemetrexed Revenue Market Share by Region in 2016
Table United States Pemetrexed Price (K USD/Unit) by Region (2012-2017)
Table United States Pemetrexed Sales (Units) by Type (2012-2017)
Table United States Pemetrexed Sales Share by Type (2012-2017)
Figure United States Pemetrexed Sales Share by Type (2012-2017)
Figure United States Pemetrexed Sales Market Share by Type in 2016
Table United States Pemetrexed Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pemetrexed Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pemetrexed by Type (2012-2017)
Figure Revenue Market Share of Pemetrexed by Type in 2016
Table United States Pemetrexed Price (K USD/Unit) by Types (2012-2017)
Figure United States Pemetrexed Sales Growth Rate by Type (2012-2017)
Table United States Pemetrexed Sales (Units) by Application (2012-2017)
Table United States Pemetrexed Sales Market Share by Application (2012-2017)
Figure United States Pemetrexed Sales Market Share by Application (2012-2017)
Figure United States Pemetrexed Sales Market Share by Application in 2016
Table United States Pemetrexed Sales Growth Rate by Application (2012-2017)
Figure United States Pemetrexed Sales Growth Rate by Application (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Pemetrexed Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Pemetrexed Sales Growth Rate (2012-2017)
Figure Eli Lilly Pemetrexed Sales Market Share in United States (2012-2017)
Figure Eli Lilly Pemetrexed Revenue Market Share in United States (2012-2017)
Table Abbott Healthcare Basic Information List
Table Abbott Healthcare Pemetrexed Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Healthcare Pemetrexed Sales Growth Rate (2012-2017)
Figure Abbott Healthcare Pemetrexed Sales Market Share in United States (2012-2017)
Figure Abbott Healthcare Pemetrexed Revenue Market Share in United States (2012-2017)
Table Cadila Healthcare Basic Information List
Table Cadila Healthcare Pemetrexed Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Cadila Healthcare Pemetrexed Sales Growth Rate (2012-2017)
Figure Cadila Healthcare Pemetrexed Sales Market Share in United States (2012-2017)
Figure Cadila Healthcare Pemetrexed Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pemetrexed
Figure Manufacturing Process Analysis of Pemetrexed
Figure Pemetrexed Industrial Chain Analysis
Table Raw Materials Sources of Pemetrexed Major Players/Suppliers in 2016
Table Major Buyers of Pemetrexed
Table Distributors/Traders List
Figure United States Pemetrexed Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Pemetrexed Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pemetrexed Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Pemetrexed Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Pemetrexed Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Pemetrexed Sales Volume (Units) Forecast by Type in 2022
Table United States Pemetrexed Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Pemetrexed Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Pemetrexed Sales Volume (Units) Forecast by Application in 2022
Table United States Pemetrexed Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Pemetrexed Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pemetrexed Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pemetrexed Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources